BRAF is a therapeutic target in aggressive thyroid carcinoma

G Salvatore, V De Falco, P Salerno, TC Nappi… - Clinical Cancer …, 2006 - AACR
Purpose: Oncogenic conversion of BRAF occurs in∼ 44% of papillary thyroid carcinomas
and 24% of anaplastic thyroid carcinomas. In papillary thyroid carcinomas, this mutation is …
被引用次数：213 相关文章

BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma

G Salvatore, V De Falco, P Salerno, TC Nappi… - Clinical Cancer …, 2006 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Oncogenic conversion of BRAF
occurs in∼ 44% of papillary thyroid carcinomas and 24% of anaplastic thyroid carcinomas …

[引用][C] BRAF is a therapeutic target in aggressive thyroid carcinoma

G SALVATORE, V DE FALCO… - Clinical cancer …, 2006 - pascal-francis.inist.fr
BRAF is a therapeutic target in aggressive thyroid carcinoma CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

BRAF is a therapeutic target in aggressive thyroid carcinoma.

G Salvatore, V DE FALCO, P Salerno… - CLINICAL CANCER …, 2006 - iris.unisa.it
PURPOSE: Oncogenic conversion of BRAF occurs in approximately 44% of papillary thyroid
carcinomas and 24% of anaplastic thyroid carcinomas. In papillary thyroid carcinomas, this …

[引用][C] BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma

G Salvatore, V DE FALCO, R Melillo… - CLINICAL …, 2006 - ricerca.uniparthenope.it
BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma IRIS IRIS Home Sfoglia
Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English English …

BRAF is a therapeutic target in aggressive thyroid carcinoma.

G Salvatore, V De Falco, P Salerno… - … Cancer Research: an …, 2006 - europepmc.org
Purpose Oncogenic conversion of BRAF occurs in approximately 44% of papillary thyroid
carcinomas and 24% of anaplastic thyroid carcinomas. In papillary thyroid carcinomas, this …

BRAF is a therapeutic target in aggressive thyroid carcinoma.

G Salvatore, V De Falco, P Salerno, TC Nappi… - CLINICAL CANCER …, 2006 - iris.unina.it
PURPOSE: Oncogenic conversion of BRAF occurs in approximately 44% of papillary thyroid
carcinomas and 24% of anaplastic thyroid carcinomas. In papillary thyroid carcinomas, this …
[PDF] academia.edu

[PDF][PDF] BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma

G Troncone, F Carlomagno, M Melillo, SM Wilhelm… - academia.edu
Purpose: Oncogenic conversion of BRAF occurs in f44% of papillary thyroid carcinomas and
24% of anaplastic thyroid carcinomas. In papillary thyroid carcinomas, this mutation is …

BRAF is a therapeutic target in aggressive thyroid carcinoma

G Salvatore, V De Falco, P Salerno… - … : an official journal …, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose Oncogenic conversion of BRAF occurs in approximately 44% of papillary thyroid
carcinomas and 24% of anaplastic thyroid carcinomas. In papillary thyroid carcinomas, this …

[引用][C] BRAF is a therapeutic target in aggressive thyroid carcinoma

G SALVATORE, V DE FALCO… - Clinical …, 2006 - American Association for Cancer …